InvestorNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Appoints European Head of Sales
Jan 18, 2022
XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator at the leading-edge of the life science industry, has named Drahoslav Zdarek as its head of sales in Europe. According to the announcement, Zdarek will focus on developing distribution, sales and marketing of the company’s products; top on the list of assignments Zdarek will be focused on is the commercialization of XPHYF’s Covid-ID Lab. The Covid-ID Lab is XPhyto’s German CE mark-approved rapid RT-PCR test registered within the European Union (“EU”) as a commercial in vitro diagnostic (“CE-IVD”) test. A licensed pharmacist and certified trainer for the Covid-ID Lab test, Zdarek has more than 25 years of pharmaceutical sales and marketing success and experience, including more than 13 years at Teva Pharmaceutical focusing on marketing and sales in the European market; he also served as head of business development at CC Pharma GmbH and head of sales at Cell Pharma GmbH. “Mr. Zdarek is an important addition to the company, joining at the right time,” said XPhyto director Thomas Beckert. “With his technical experience as well as sales skills, he will help expand our European distribution and sales networks.”
To view the full press release, visit https://ibn.fm/pyWJp
About XPhyto Therapeutics Corp.
XPhyto Therapeutics is a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment opportunities, including precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral-health screening tests; and standardization of emerging active pharmaceutical ingredients for neurological applications, including psychedelic compounds and cannabinoids. XPhyto has research and development operations in North America and Europe, with an operational focus in Germany. The company is currently focused on regulatory approval and commercialization of medical products for European markets. For more information about this company, please visit www.XPhyto.com
NOTE TO INVESTORS: The latest news and updates relating to XPHYF are available in the company’s newsroom at https://ibn.fm/XPHYF
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork.
More News
Rising Interest Rates Are Causing Alarm. Here’s What to Know.
History shows that the markets and the economy flourished when rates were even higher than today’s. But, our columnist notes, those times didn’t last.
Why a U.S. Diesel Export Ban May Not Lower Prices
President Trump has said he is considering restricting overseas sales of the fuel to bring down domestic prices, but experts say the policy will have many unintended effects.
How Climate Change Is Disrupting Summer Travel
Once dismissed as occasional inconveniences, climate-related disruptions are now an inescapable fixture of summer travel. How will travelers respond?
The World Needs Better Power Grids. Why Smaller May Be Better.
Jonas Birgersson, a Swedish entrepreneur, wants to use decentralized networks modeled on the internet to transform how electricity is distributed.
TikTok and Instagram Creators Have Turned NYC Into an Unofficial Soundstage
The streets of New York are a backdrop for countless TikTok and Instagram videos.
Mark Zuckerberg Is Trying Something On
Meta’s C.E.O. talks for the first time about his style evolution.
Europe's car makers are in crisis. Will the threat of war rescue them?
Auto executives across Europe hope rearmament can help them flex their industrial muscles once more.
Africa's richest man helps fund $660m fuel pipeline between Ethiopia and Djibouti
The pipeline would strengthen energy security in landlocked Ethiopia, while creating jobs at Djibouti's port.
Farmers down 240 million litres of milk after heat
Milk yield was affected by a series of extreme heatwaves which led to poor grazing conditions, researchers say.
What's the smallest amount you'd ask a friend to pay back?
We ask New Yorkers to share the smallest amount they'd ask a friend to pay back.
We ship our gym equipment all over the world
Northern Ireland's economic output, which is broadly equivalent to UK GDP, rose by 2.3% in the year to June.
Scam hotel booking sent family to Wetherspoon pub
Which? says staff are turning away up to 20 tourists a day after scammers used the pub's address.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.